Joanna Dreux MS

Second Genome

Appearances

Short Talk: Microbiome‑Based Biomarker Predicts Response to Immune Checkpoint Inhibitor Therapy Independently of Clinical Features in a Melanoma Meta Cohort
Date
January 19, 2021
Speaker
Joanna Dreux, MS
Second Genome

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.

Joanna Dreux MS

Second Genome

Appearances

Short Talk: Microbiome‑Based Biomarker Predicts Response to Immune Checkpoint Inhibitor Therapy Independently of Clinical Features in a Melanoma Meta Cohort

Speaker